Parliament Workbench
Data: Official Report to 17 Nov 2026

Official Report · Chamber

Mesh Implants (National Health Service)

Topical Question Time

Tuesday 13 May 2014 Meeting of the Parliament Questions 14 contributions · 6 speakers Watch on Scottish Parliament TV

Speakers

Choose an MSP to read only their contributions

The record

14 contributions
Neil Findlay Lab Lothian
link

To ask the Scottish Government, in light of the recent reclassification of mesh implants as high risk in the United States, when mesh implants will be banned in the NHS in Scotland. (S4T-00695)

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

The Cabinet Secretary for Health and Wellbeing has written to both the Medicines and Healthcare products Regulatory Agency and the European Commission, asking that they urgently consider the United States Food and Drug Administration’s proposed reclassification of surgical mesh for the treatment of pelvic organ prolapse. The European Commission is seeking further research and expert opinion. The cabinet secretary has asked for assurance that it will act quickly, once the research is available, to reclassify these devices if the evidence points to that requirement.

Neil Findlay Lab Lothian
link

The complications for many women after the implant of a mesh device are devastating, leaving them disabled, in chronic pain and facing a life of multiple operations and uncertainty. In the US and Australia, mass class actions are being taken against the manufacturers, which are pending.

The Scottish Government originally told me, in answer to a parliamentary question, that only six women in Scotland have suffered an adverse impact of a mesh implant. That figure then rose to 101 women, but a freedom of information request that I submitted to health boards revealed that more than 330 women have had to have mesh fully or partially removed. In addition, more than 10,000 women have had an implant despite a parliamentary answer that suggested that the number is 2,000.

Tricia Marwick The Presiding Officer · Mid Fife and Glenrothes
link

Mr Findlay, can we have a question?

Neil Findlay Lab Lothian
link

Does the minister now have definitive numbers for those who have had an implant and those who have suffered complications?

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

We have a range of figures for the number of procedures that were undertaken in which transvaginal mesh implants were used. Those figures go back to 2007-08 and up to 2012-13. I am more than happy to provide the member with the annual breakdown of those figures.

We do not have specific figures relating to problems with a particular product, because information relating to a specific product is not recorded in a patient’s medical notes. However, the Government is pursuing a programme of work on how the medical implant that is used in a procedure can be recorded in the patient’s electronic record so that we have a much clearer picture of the number of patients who may be affected should problems develop with a particular medical implant.

Neil Findlay Lab Lothian
link

Despite the large numbers, the Scottish Government has been reluctant to suspend the use of mesh devices, apparently out of concern that the manufacturers will instigate legal action against the Scottish Government. Is the minister still concerned that the Scottish Government could face legal action from manufacturers, or has he changed his mind and is he now ready to put the women of Scotland first, before any legal concerns that he may have? Does he have the same concern about the legal action that is being pursued by those who have been horribly injured by these products?

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

The Government’s sympathy is with any woman who has suffered a complication as a result of treatment that has involved the use of these medical products. However, the member will understand that the products are regulated by the MHRA and the European Commission, and we must be led by their guidance on the matter. Unlike other regulatory bodies around the world, the MHRA in the United Kingdom is not recommending that the products should not be used at this time.

Nevertheless, we have asked for an urgent meeting with the MHRA to ask what action it intends to take as a result of the FDA’s actions in the US. Equally, we have asked the European Commission to be very clear about the two pieces of research that it is undertaking to ensure that, once we have the findings of those research projects, action is taken quickly. If a reclassification of the products is recommended, we will act on that. We have to work within the regulatory function that we have at present, but the member can be reassured that, if there is any change to the guidance or a recommendation is made by the MHRA or the European Commission, the Government will act swiftly on that.

John Scott Con The Deputy Presiding Officer · Ayr
link

Given the emerging worldwide concerns about mesh implants and the difficulties and costs associated with removing them, can the minister assure our Parliament and our constituents that the Scottish Government will issue fresh guidance to NHS boards on the use of mesh implants, will take a more open approach to dealing with legitimate concerns and will be prepared to play its part in a worldwide collaborative approach to resolving this emerging problem?

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

The cabinet secretary has established a working group to look at the issue, and one of its early actions will be to produce an information and consent form for women who undergo, or who are thinking of undergoing, this procedure. The working group intends to issue that form shortly, and we will roll it out across the NHS so that women are fully informed about the procedure and the issues associated with it.

The member also made reference to the impact on those women who suffer complications. Another piece of work that the expert group is doing is on the patient pathway for such women. The aim is to ensure that that pathway is robust and clear, and that they receive the early treatment that they require.

Of course, if there is a need for us to engage with authorities in the rest of the world, we will be more than happy to do so, but I hope that the member is reassured by the actions that the cabinet secretary has taken to ensure that, where a change is made to any of the recommendations to do with this procedure and this type of device, we will act quickly in NHS Scotland.

Bob Doris SNP Glasgow
link

Have any risks been identified that relate to the use of other mesh devices, such as hernia mesh? Has the use of such devices been affected by the decision in the United States?

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

I am afraid that I can refer only to the proposal from the FDA, which I understand relates to the use of pelvic organ prolapse mesh; I cannot comment on mesh that is used for other procedures.

It is worth pointing out that, to date, the evidence does not point to a particular product produced by a particular manufacturer. It is important that we ensure that the public can have confidence in this procedure. The University of York is doing a piece of work to look at the use of mesh for the procedure and at the use of natural tissue, and to find out which has better outcomes for patients. Once we have the findings of that work from the MHRA, we will be in a position to consider how it can be rolled out to clinicians in NHS Scotland.

Margaret Mitchell Con Central Scotland
link

In February 2007, a constituent of mine was one of the first people to have a mesh implant. Within weeks, she knew that something was very far wrong. Consequently, she had some of it removed in 2008 and January 2014. What advice was given to those who took part in the pilot programme for the mesh implants? It is my constituent’s understanding that the Scottish Government made funding available for the removal of those implants in 2008 but, because of the number of cases involved, the Government had a change of heart when it realised the severity of the situation and the funding was removed. Was that the case?

Michael Matheson SNP The Minister for Public Health · Falkirk West
link

In relation to the latter point, I have no recollection whatever of that happening. If there are patients who require a medical intervention on the basis that they are suffering from complications that relate to the use of a particular medical device in a previous procedure, we would expect clinicians to take that forward in the appropriate way. That is a matter for clinical rather than ministerial decision making.

As far as the member’s specific point about her constituent is concerned, if she writes to me with the details of that case, I will be more than happy to ensure that it is looked into and that she gets a full and detailed response.

Motions, questions and votes

Linked from this item of the Official Report
  1. Time for Reflection Time for reflection · 2
  2. Business Motions Business motions · 4
  3. Mesh Implants (National Health Service) Questions · 14
  4. North Sea Oil (Wealth Fund) Questions · 11
  5. Procurement Reform (Scotland) Bill: Stage 3 Bill debate · 196
  6. Procurement Reform (Scotland) Bill Bill debate · 22
  7. Decision Time Decision time · 1
  8. Asbestos-related Conditions (Healthcare Costs Recovery) Members’ business · 12

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.